Improvement of islet allograft function using cibinetide, an innate repair receptor ligand

Ming Yao, Masaaki Watanabe, Sune Sun, Kazuaki Tokodai, Anthony Cerami, Michael Brines, Claes Göran Östenson, Bo Göran Ericzon, Torbjörn Lundgren, Makiko Kumagai-Braesch

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Background. During intraportal pancreatic islet transplantation (PITx), early inflammatory reactions cause an immediate loss of more than half of the transplanted graft and potentiate subsequent allograft rejection. Previous findings suggest that cibinetide, a selective innate repair receptor agonist, exerts islet protective and antiinflammatory properties and improved transplant efficacy in syngeneic mouse PITx model. In a stepwise approach toward a clinical application, we have here investigated the short- and long-term effects of cibinetide in an allogeneic mouse PITx model. Methods. Streptozotocin-induced diabetic C57BL/6N (H-2b) mice were transplanted with 320 (marginal) or 450 (standard) islets from BALB/c (H-2d) mice via the portal vein. Recipients were treated perioperative and thereafter daily during 14 d with cibinetide (120 µg/kg), with or without tacrolimus injection (0.4 mg/kg/d) during days 4-14 after transplantation. Graft function was assessed using nonfasting glucose measurements. Relative gene expressions of proinflammatory cytokines and proinsulin of the graft-bearing liver were assessed by quantitative polymerase chain reaction. Cibinetide's effects on dendritic cell maturation were investigated in vitro. Results. Cibinetide ameliorated the local inflammatory responses in the liver and improved glycemic control immediately after allogeneic PITx and significantly delayed the onset of allograft loss. Combination treatment with cibinetide and low-dose tacrolimus significantly improved long-term graft survival following allogeneic PITx. In vitro experiments indicated that cibinetide lowered bone-marrow-derived-immature-dendritic cell maturation and subsequently reduced allogeneic T-cell response. Conclusions. Cibinetide reduced the initial transplantation-related severe inflammation and delayed the subsequent alloreactivity. Cibinetide, in combination with low-dose tacrolimus, could significantly improve long-term graft survival in allogeneic PITx.

Original languageEnglish
Pages (from-to)2048-2058
Number of pages11
Publication statusAccepted/In press - 2020
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Improvement of islet allograft function using cibinetide, an innate repair receptor ligand'. Together they form a unique fingerprint.

Cite this